Dr. Barbara Mroczko is a Professor at the Department of Neurodegeneration Diagnostics, Medical University of Bialystok, Poland. She is also the Head of the Department of Neurodegeneration Diagnostics (since 2012), Head of the Department of Biochemical Diagnostics (since 2018), and Director of the Doctoral School (since 2019) at the Medical University of Bialystok. She is a member of the Polish Society of Laboratory Diagnostics, the Polish Society of Internal Medicine, the Polish Society of Gastroenterology, the College of Laboratory Medicine in Poland, and the Alzheimer’s Association International Society to Advance Alzheimer's Research and Treatment (ISTAART). Her research interests are focused on the assessment of the clinical significance of selected specific proteins, such as matrix metalloproteinases (e.g., MMP-2, MMP-9) and tissue inhibitors of metalloproteinases (e.g., TIMP-1, TIMP-2), as well as pro-inflammatory mediators (hematopoietic cytokines, chemokines, and their specific receptors), as potential candidates for biomarkers of cancers and neurodegenerative diseases. She has published 269 scientific publications and 173 congress reports. Hirsch index: 38, total times cited: 5995 (Scopus, 13 November 2023).